Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 166

1.

Effects of Renal Denervation Documented in the Austrian National Multicentre Renal Denervation Registry.

Zweiker D, Lambert T, Steinwender C, Weber T, Suppan M, Brussee H, Koppelstätter C, Kerschbaum J, Watschinger B, Hohenstein-Scheibenecker K, Reindl-Schwaighofer R, Sturmberger T, Kindslehner C, Weiss TW, Rohla M, Gruener P, Maister P, Auer J, Dechant C, Sykora J, Krismer C, Glaser S, Zweiker R.

PLoS One. 2016 Aug 16;11(8):e0161250. doi: 10.1371/journal.pone.0161250. eCollection 2016.

2.

Hypertension and coronary artery disease: epidemiology, physiology, effects of treatment, and recommendations : A joint scientific statement from the Austrian Society of Cardiology and the Austrian Society of Hypertension.

Weber T, Lang I, Zweiker R, Horn S, Wenzel RR, Watschinger B, Slany J, Eber B, Roithinger FX, Metzler B.

Wien Klin Wochenschr. 2016 Jul;128(13-14):467-79. doi: 10.1007/s00508-016-0998-5. Epub 2016 Jun 9.

PMID:
27278135
3.

DAA-based antiviral treatment of patients with chronic hepatitis C in the pre- and postkidney transplantation setting.

Beinhardt S, Al Zoairy R, Ferenci P, Kozbial K, Freissmuth C, Stern R, Stättermayer AF, Stauber R, Strasser M, Zoller H, Watschinger B, Schmidt A, Trauner M, Hofer H, Maieron A.

Transpl Int. 2016 Sep;29(9):999-1007. doi: 10.1111/tri.12799. Epub 2016 Jul 7.

4.

Austrian Lipid Consensus on the management of metabolic lipid disorders to prevent vascular complications: A joint position statement issued by eight medical societies. 2016 update.

Toplak H, Ludvik B, Lechleitner M, Dieplinger H, Föger B, Paulweber B, Weber T, Watschinger B, Horn S, Wascher TC, Drexel H, Brodmann M, Pilger E, Rosenkranz A, Pohanka E, Oberbauer R, Traindl O, Roithinger FX, Metzler B, Haring HP, Kiechl S.

Wien Klin Wochenschr. 2016 Apr;128 Suppl 2:S216-28. doi: 10.1007/s00508-016-0993-x.

5.

[Antihypertensive therapy in diabetes mellitus: Guidelines of the Austrian Diabetes Association 2016].

Schernthaner G, Drexel H, Rosenkranz A, Schernthaner GH, Watschinger B.

Wien Klin Wochenschr. 2016 Apr;128 Suppl 2:S62-7. doi: 10.1007/s00508-015-0924-2. Review. German.

PMID:
27052224
6.

Long-term outcome of belatacept therapy in de novo kidney transplant recipients - a case-match analysis.

Schwarz C, Mayerhoffer S, Berlakovich GA, Steininger R, Soliman T, Watschinger B, Böhmig GA, Eskandary F, König F, Mühlbacher F, Wekerle T.

Transpl Int. 2015 Jul;28(7):820-7. doi: 10.1111/tri.12544. Epub 2015 Mar 6.

7.

[Austrian Society of Hypertension].

Watschinger B.

Wien Klin Wochenschr. 2014 Apr;126(7-8):254-5. doi: 10.1007/s00508-014-0511-y. German. No abstract available.

PMID:
24668186
8.

The MAINTAIN study--managing hemoglobin variability with darbepoetin alfa in dialysis patients experiencing a severe drop in hemoglobin.

Watschinger B, Salmhofer H, Horn S, Neyer U, Wiesinger T, Wiesholzer M, Erb H, Jaeger C, Hemetsberger M, Rosenkranz AR.

Wien Klin Wochenschr. 2013 Feb;125(3-4):71-82. doi: 10.1007/s00508-012-0311-1. Epub 2013 Jan 9.

PMID:
23299452
9.

[Antihypertensive therapy in diabetes mellitus - 2012 guidelines of the Austrian Diabetes Association].

Schernthaner G, Drexel H, Rosenkranz AR, Schernthaner GH, Watschinger B; Ausrian Diabetes Association.

Wien Klin Wochenschr. 2012 Dec;124 Suppl 2:23-7. doi: 10.1007/s00508-012-0270-6. German.

PMID:
23250458
10.

Clinical application of interventional renal sympathetic denervation: recommendations of the Austrian Society of Hypertension 2012.

Weber T, Zweiker R, Watschinger B, Grüner P, Koppelstätter C, Brandt MC, Horina J, Brussee H, Hohenstein K, Lambert T, Auer J, Hoppe UC.

Wien Klin Wochenschr. 2012 Nov;124(21-22):789-98. doi: 10.1007/s00508-012-0257-3. Epub 2012 Nov 27.

PMID:
23184070
11.

Cardiorenal end points in a trial of aliskiren for type 2 diabetes.

Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Persson F, Desai AS, Nicolaides M, Richard A, Xiang Z, Brunel P, Pfeffer MA; ALTITUDE Investigators.

N Engl J Med. 2012 Dec 6;367(23):2204-13. doi: 10.1056/NEJMoa1208799. Epub 2012 Nov 3.

12.

Anemia in solid organ transplantation.

Małyszko J, Watschinger B, Przybyłowski P, Durlik M.

Ann Transplant. 2012 Apr-Jun;17(2):86-100. Review.

PMID:
22743727
13.

Anemia and erythrocytosis in patients after kidney transplantation.

Malyszko J, Oberbauer R, Watschinger B.

Transpl Int. 2012 Oct;25(10):1013-23. doi: 10.1111/j.1432-2277.2012.01513.x. Epub 2012 Jun 21. Review.

14.

[Hypertension and nutrition. Position paper of the Austrian Nutrition Society].

Dorner TE, Genser D, Krejs G, Slany J, Watschinger B, Ekmekcioglu C, Rieder A.

Herz. 2013 Mar;38(2):153-62. doi: 10.1007/s00059-012-3613-1. Epub 2012 May 17. Review. German.

PMID:
22588364
15.

Clinical diagnosis of metabolic syndrome: predicting new-onset diabetes, coronary heart disease, and allograft failure late after kidney transplant.

Israni AK, Snyder JJ, Skeans MA, Kasiske BL; PORT Investigators.

Transpl Int. 2012 Jul;25(7):748-57. doi: 10.1111/j.1432-2277.2012.01488.x. Epub 2012 Apr 30.

16.

Recurrent circumflex artery embolization due to a free-floating fibroelastoma at the aortic valve.

Gremmel T, Pfaffenberger S, Binder T, Kocher A, Watschinger B.

Ann Thorac Surg. 2011 May;91(5):1626. doi: 10.1016/j.athoracsur.2010.09.062. No abstract available.

PMID:
21524483
17.

The relationship between kidney function and long-term graft survival after kidney transplant.

Kasiske BL, Israni AK, Snyder JJ, Skeans MA; Patient Outcomes in Renal Transplantation (PORT) Investigators.

Am J Kidney Dis. 2011 Mar;57(3):466-75. doi: 10.1053/j.ajkd.2010.10.054. Epub 2011 Jan 22.

PMID:
21257243
18.

Effective use of cinacalcet for the treatment of secondary hyperparathyroidism in Austrian dialysis patients--results of the Austrian cohort of the ECHO study.

Zitt E, Jäger C, Rosenkranz AR, Eigner M, Kodras K, Kovarik J, Graf H, Pétavy F, Horn S, Watschinger B.

Wien Klin Wochenschr. 2011 Jan;123(1-2):45-52. doi: 10.1007/s00508-010-1515-x. Epub 2011 Jan 21.

PMID:
21253777
19.

Predicting coronary heart disease after kidney transplantation: Patient Outcomes in Renal Transplantation (PORT) Study.

Israni AK, Snyder JJ, Skeans MA, Peng Y, Maclean JR, Weinhandl ED, Kasiske BL; PORT Investigators.

Am J Transplant. 2010 Feb;10(2):338-53. doi: 10.1111/j.1600-6143.2009.02949.x.

20.

Prevalence of NSF following intravenous gadolinium-contrast media administration in dialysis patients with endstage renal disease.

Heinz-Peer G, Neruda A, Watschinger B, Vychytil A, Geusau A, Haumer M, Weber M.

Eur J Radiol. 2010 Oct;76(1):129-34. doi: 10.1016/j.ejrad.2009.06.028. Epub 2009 Jul 19.

PMID:
19619969

Supplemental Content

Loading ...
Support Center